For example, miR-216a overexpression can promote breast cancer cell apoptosis by targeting protein kinase C alpha (PKCα) (Cui et al., 2019) and increase cell apoptosis in response to gemcitabine in the pancreatic cancer cells (Zhang et al., 2017). This evidence concerns the gene PRKCA and breast cancer.